Research Article
ARID1A Is a Prognostic Biomarker and Associated with Immune Infiltrates in Hepatocellular Carcinoma
Table 2
Univariate and multivariate analysis of the relationship between ARID1A expression and overall survival among LIHC patients.
| Id | UniCox | MultiCox | HR | HR.95L | HR.95H | P value | HR | HR.95L | HR.95H | P value |
| Age | 1.0050 | 0.9869 | 1.0235 | 0.5912 | 1.0095 | 0.9904 | 1.0290 | 0.3310 | Gender | 0.7801 | 0.4872 | 1.2492 | 0.3013 | 1.0806 | 0.6417 | 1.8196 | 0.7706 | Grade | 1.0172 | 0.7459 | 1.3871 | 0.9143 | 1.1027 | 0.7933 | 1.5327 | 0.5608 | Stage | 1.4172 | 1.2349 | 1.6265 | ≤0.001 | 0.7728 | 0.3338 | 1.7894 | 0.5474 | T | 1.8044 | 1.4341 | 2.2702 | ≤0.001 | 2.1529 | 1.0004 | 4.6332 | 0.0499 | M | 3.8498 | 1.2068 | 12.2813 | 0.0228 | 3.8978 | 0.1478 | 102.7721 | 0.4151 | N | 2.0218 | 0.4939 | 8.2761 | 0.3276 | 2.5713 | 0.4881 | 13.5439 | 0.2653 | ARID1A | 1.0985 | 1.0341 | 1.1669 | 0.0023 | 1.0682 | 1.0004 | 1.1406 | 0.0487 |
|
|